本頁面由Tiger Trade Technology Pte. Ltd.提供服務

X4製藥

3.50
-0.0150-0.43%
成交量:40.69萬
成交額:142.07萬
市值:3.47億
市盈率:-3.94
高:3.59
開:3.56
低:3.41
收:3.51
52周最高:4.83
52周最低:2.80
股本:9,914.67萬
流通股本:6,235.43萬
量比:0.33
換手率:0.65%
股息:- -
股息率:- -
每股收益(TTM):-0.8867
每股收益(LYR):-1.8726
淨資產收益率:-113.08%
總資產收益率:-28.15%
市淨率:2.23
市盈率(LYR):-1.87

資料載入中...

2025/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/16

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/23

SEC問詢函

Form CORRESP - Correspondence
2024/11/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/13

重要事件披露

Form 8-K - Current report
2024/10/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/16

重要事件披露

Form 8-K - Current report